PMID: 11916611Mar 28, 2002Paper

Graves' ophthalmopathy: a preventable disease?

European Journal of Endocrinology
L BartalenaA Pinchera

Abstract

Most patients with Graves' disease have some degree of ocular involvement, but only 3-5% of them develop severe ophthalmopathy (1). The reasons why only such a minority of patients with Graves' disease have severe expression of the ophthalmopathy remain to be elucidated. One possible explanation is that non-severe ophthalmopathy and severe ophthalmopathy are two different disorders with different genetic backgrounds; alternatively, they might be part of a spectrum of different conditions ranging from absent ocular involvement to most severe ophthalmopathy. In this case, external variables (i.e. environmental factors) must contribute to the nature of the expression of the disease. How important are they? How far can our intervention on environmental factors go towards reducing the risk of progression of the ophthalmopathy? In other words, to which extent, if any, is Graves' ophthalmopathy preventable? The aim of this mini-review is to address the above issues.

Citations

Apr 16, 2010·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·I SterkerD Führer
Mar 18, 2008·Thyroid : Official Journal of the American Thyroid Association·Luigi BartalenaWilmar M Wiersinga
Sep 7, 2006·Postgraduate Medical Journal·L D K E Premawardhana, J H Lazarus
May 29, 2004·Journal of Endocrinological Investigation·L HegediüsP Vestergaard
Aug 4, 2005·Journal of Endocrinological Investigation·L Bartalena
Aug 4, 2005·Journal of Endocrinological Investigation·L BartalenaA Pinchera
Aug 30, 2008·Thyroid : Official Journal of the American Thyroid Association·Geniece M LehmannRichard P Phipps
May 29, 2012·Best Practice & Research. Clinical Endocrinology & Metabolism·Luigi Bartalena
Apr 14, 2010·Survey of Ophthalmology·Vibhavari M NaikRaymond S Douglas
May 30, 2006·Hematology/oncology Clinics of North America·Tony Y EngC R Thomas
May 28, 2004·Clinical Endocrinology·A de BellisA Bizzarro
May 25, 2007·Clinical Endocrinology·Tomasz BednarczukJack R Wall
Jul 23, 2008·Ophthalmic Plastic and Reconstructive Surgery·Luigi BartalenaMaria Laura Tanda
Nov 6, 2010·Korean Journal of Ophthalmology : KJO·Ji Hwan LeeJin Sook Yoon
Mar 8, 2011·The Journal of Clinical Endocrinology and Metabolism·Andrew J Bauer
May 1, 2008·Expert Review of Clinical Immunology·Luigi BartalenaMaria Laura Tanda
May 29, 2004·Journal of Endocrinological Investigation·L BartalenaA Pinchera
Mar 21, 2021·International Ophthalmology Clinics·Thai H Do, Alon Kahana
Feb 20, 2021·Current Opinion in Ophthalmology·Alon Kahana
Jul 20, 2010·Neurologic Clinics·Kimberly P Cockerham, Stephanie S Chan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Thyroid : Official Journal of the American Thyroid Association
W M Wiersinga, L Bartalena
Tissue Antigens
S G E Marsh, WHO Nomenclature Committee for Factors of the HLA System
© 2022 Meta ULC. All rights reserved